vs

Side-by-side financial comparison of KINGSWAY FINANCIAL SERVICES INC (KFS) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $38.6M, roughly 1.9× KINGSWAY FINANCIAL SERVICES INC). On growth, KINGSWAY FINANCIAL SERVICES INC posted the faster year-over-year revenue change (30.1% vs -36.9%). Over the past eight quarters, KINGSWAY FINANCIAL SERVICES INC's revenue compounded faster (21.4% CAGR vs -34.4%).

Kingsway Financial Services Inc. is a specialty financial holding firm that primarily offers property and casualty insurance products, including personal auto, commercial liability and property coverage. It operates mainly across North American markets, catering to individual consumers, small business owners and niche commercial client segments.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

KFS vs MED — Head-to-Head

Bigger by revenue
MED
MED
1.9× larger
MED
$75.1M
$38.6M
KFS
Growing faster (revenue YoY)
KFS
KFS
+67.0% gap
KFS
30.1%
-36.9%
MED
Faster 2-yr revenue CAGR
KFS
KFS
Annualised
KFS
21.4%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KFS
KFS
MED
MED
Revenue
$38.6M
$75.1M
Net Profit
$-1.6M
Gross Margin
69.4%
Operating Margin
0.8%
-10.4%
Net Margin
-4.1%
Revenue YoY
30.1%
-36.9%
Net Profit YoY
-7.8%
EPS (diluted)
$-0.07
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KFS
KFS
MED
MED
Q4 25
$38.6M
$75.1M
Q3 25
$37.2M
$89.4M
Q2 25
$30.9M
$105.6M
Q1 25
$28.3M
$115.7M
Q4 24
$29.6M
$119.0M
Q3 24
$27.1M
$140.2M
Q2 24
$26.4M
$168.6M
Q1 24
$26.2M
$174.7M
Net Profit
KFS
KFS
MED
MED
Q4 25
$-1.6M
Q3 25
$-2.4M
$-2.3M
Q2 25
$-3.2M
$2.5M
Q1 25
$-3.1M
$-772.0K
Q4 24
$-1.5M
Q3 24
$-2.3M
$1.1M
Q2 24
$-2.2M
$-8.2M
Q1 24
$-2.3M
$8.3M
Gross Margin
KFS
KFS
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
KFS
KFS
MED
MED
Q4 25
0.8%
-10.4%
Q3 25
-2.3%
-4.6%
Q2 25
-3.6%
-1.0%
Q1 25
-2.5%
-1.1%
Q4 24
6.5%
0.6%
Q3 24
-2.5%
1.5%
Q2 24
0.5%
-4.7%
Q1 24
2.9%
4.5%
Net Margin
KFS
KFS
MED
MED
Q4 25
-4.1%
Q3 25
-6.5%
-2.5%
Q2 25
-10.2%
2.3%
Q1 25
-10.9%
-0.7%
Q4 24
-5.0%
Q3 24
-8.5%
0.8%
Q2 24
-8.3%
-4.8%
Q1 24
-8.9%
4.8%
EPS (diluted)
KFS
KFS
MED
MED
Q4 25
$-0.07
$-1.64
Q3 25
$-0.10
$-0.21
Q2 25
$-0.13
$0.22
Q1 25
$-0.13
$-0.07
Q4 24
$-0.08
$0.08
Q3 24
$-0.10
$0.10
Q2 24
$-0.08
$-0.75
Q1 24
$-0.09
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KFS
KFS
MED
MED
Cash + ST InvestmentsLiquidity on hand
$8.5M
$167.3M
Total DebtLower is stronger
$70.7M
Stockholders' EquityBook value
$15.2M
$198.9M
Total Assets
$231.5M
$248.0M
Debt / EquityLower = less leverage
4.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KFS
KFS
MED
MED
Q4 25
$8.5M
$167.3M
Q3 25
$9.5M
$173.5M
Q2 25
$12.3M
$162.7M
Q1 25
$6.5M
$164.6M
Q4 24
$5.7M
$162.3M
Q3 24
$6.7M
$170.0M
Q2 24
$9.8M
$163.5M
Q1 24
$12.3M
$156.4M
Total Debt
KFS
KFS
MED
MED
Q4 25
$70.7M
Q3 25
$70.7M
Q2 25
$58.3M
Q1 25
$59.5M
Q4 24
$57.5M
Q3 24
$58.5M
Q2 24
$47.3M
Q1 24
$47.1M
Stockholders' Equity
KFS
KFS
MED
MED
Q4 25
$15.2M
$198.9M
Q3 25
$16.6M
$214.7M
Q2 25
$17.4M
$216.0M
Q1 25
$5.5M
$211.0M
Q4 24
$8.4M
$210.1M
Q3 24
$9.9M
$207.3M
Q2 24
$20.7M
$205.3M
Q1 24
$23.6M
$211.0M
Total Assets
KFS
KFS
MED
MED
Q4 25
$231.5M
$248.0M
Q3 25
$235.1M
$268.2M
Q2 25
$207.7M
$269.3M
Q1 25
$192.1M
$280.0M
Q4 24
$186.6M
$284.2M
Q3 24
$191.1M
$291.2M
Q2 24
$192.3M
$293.5M
Q1 24
$198.0M
$302.8M
Debt / Equity
KFS
KFS
MED
MED
Q4 25
4.66×
Q3 25
4.25×
Q2 25
3.34×
Q1 25
10.91×
Q4 24
6.84×
Q3 24
5.88×
Q2 24
2.29×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KFS
KFS
MED
MED
Operating Cash FlowLast quarter
$-3.0K
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KFS
KFS
MED
MED
Q4 25
$-3.0K
$-5.3M
Q3 25
$1.5M
$12.1M
Q2 25
$337.0K
$-3.4M
Q1 25
$-1.8M
$3.4M
Q4 24
$1.1M
$-4.9M
Q3 24
$368.0K
$9.1M
Q2 24
$557.0K
$13.1M
Q1 24
$249.0K
$7.3M
Free Cash Flow
KFS
KFS
MED
MED
Q4 25
$-6.6M
Q3 25
$1.3M
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
Q3 24
$7.7M
Q2 24
$11.1M
Q1 24
$5.4M
FCF Margin
KFS
KFS
MED
MED
Q4 25
-8.8%
Q3 25
3.4%
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
Q3 24
5.5%
Q2 24
6.6%
Q1 24
3.1%
Capex Intensity
KFS
KFS
MED
MED
Q4 25
1.8%
Q3 25
0.5%
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
Q3 24
0.0%
1.0%
Q2 24
1.1%
Q1 24
1.1%
Cash Conversion
KFS
KFS
MED
MED
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KFS
KFS

Other$14.8M38%
Roundhouse Electric Equipment Co Inc$9.7M25%
MLC Plumbing LLC$5.7M15%
Systems Products International Incspi$3.8M10%
Advanced Plumbing And Drain$2.9M8%
Southside Plumbing$1.7M4%

MED
MED

Segment breakdown not available.

Related Comparisons